The Pharmaceutical Market: Hungary added to Piribo.com

Dec. 13, 2010 - PRLog -- Hungary is a landlocked country in Central Europe. The population stands at 9.9 million in 2010, of whom 16.0% are aged 65 or over. Hungary is one of the ten countries that joined the EU in May 2004. EU Directives have been transposed into national legislation; Directive 2004/27/EC was implemented in November 2005.

Funding for healthcare in Hungary is managed by the National Health Insurance Fund Administration (NHIFA), which runs the only health insurance fund in the country. In February 2008, a new bill on health insurance was signed into law, which enabled private companies to buy shares in 22 new health funds. However, the legislation was repealed in May 2008 and the health funds are to be phased out.

The Hungarian market for pharmaceuticals is expected to grow at a moderate CAGR between 2010 and 2015. Around three quarters of the pharmaceutical market is supplied by imports, which continue to grow strongly. Leading suppliers include France, Belgium and Germany.

Sources of funding for pharmaceuticals include the pharmaceutical industry itself as drug companies have been forced to contribute part of their turnover to the Health Insurance Fund, in order to cover government overspending. The Pharma Economic Act, which came into force in January 2007, successfully prevented the drugs budget from running into deficit for the first time in over a decade.

Piribo product ID: ESP000002
http://www.piribo.com/publications/country_reports/pharma...

Hungary Pharmaceutical Reports
http://www.piribo.com/pharmaceutical_markets/europe_east/...

# # #

Piribo http://www.piribo.com is the source for information products concerning the global biotechnology and pharmaceutical industries. Here you can browse and buy thousands of business information studies, market reports and books. Piribo has ongoing relationships with leading market research and publishing companies, so we can offer you a current and comprehensive range of specialised intelligence.